{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:19:54Z","timestamp":1790489994780,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0137706","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T19:24:03Z","timestamp":1441826643000},"page":"e0137706","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients"],"prefix":"10.1371","volume":"10","author":[{"given":"Tarek K.","family":"Motawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohda A.","family":"El-Maraghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Senousy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma","volume":"134","author":"HB El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"ref2","article-title":"Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER","author":"LS Freedman","year":"2006"},{"issue":"Suppl 2","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvh.12120","article-title":"The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference","volume":"20","author":"A Hatzakis","year":"2013","journal-title":"J Viral Hepat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"JA Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/bjc.2013.481","article-title":"HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study","volume":"109","author":"AM Attallah","year":"2013","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.gpb.2013.05.007","article-title":"An integrative meta-analysis of microRNAs in hepatocellular carcinoma","volume":"11","author":"M ElHefnawi","year":"2013","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjc.6606010","article-title":"The role of microRNAs in liver cancer progression","volume":"104","author":"S Huang","year":"2011","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/1078-0432.CCR-09-2123","article-title":"Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes","volume":"16","author":"C Braconi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4149\/neo_2013_018","article-title":"Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma","volume":"60","author":"J Qi","year":"2013","journal-title":"Neoplasma"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3748\/wjg.v19.i30.4887","article-title":"Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors","volume":"19","author":"H Matsumura","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease","volume":"136","author":"AS Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3350\/cmh.2012.18.4.347","article-title":"Hepatitis C virus and hepatocarcinogenesis","volume":"18","author":"SW Jeong","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"S Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.26296","article-title":"Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression","volume":"58","author":"S Shrivastava","year":"2013","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"JM Llovet","year":"2003","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"T Poynard","year":"1997","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.22919","article-title":"MicroRNA-195 suppresses tumorigenicity and regulates G1\/S transition of human hepatocellular carcinoma cells","volume":"50","author":"T Xu","year":"2009","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1158\/0008-5472.CAN-08-1569","article-title":"p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest","volume":"68","author":"CJ Braun","year":"2008","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.22749","article-title":"Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"S Ura","year":"2009","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng1855","article-title":"Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster","volume":"38","author":"M Dews","year":"2006","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.molonc.2012.04.001","article-title":"Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation","volume":"6","author":"ZB Han","year":"2012","journal-title":"Mol Oncol"},{"key":"ref22","article-title":"The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines","author":"A Henrici","year":"2013","journal-title":"Mol Carcinog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ccr.2008.10.005","article-title":"miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells","volume":"14","author":"T Wurdinger","year":"2008","journal-title":"Cancer Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1093\/nar\/gkr492","article-title":"MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region","volume":"39","author":"AR Yoon","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1073\/pnas.1105398108","article-title":"NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies","volume":"108","author":"JL Zhao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/ol.2012.810","article-title":"Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling","volume":"4","author":"Y Katayama","year":"2012","journal-title":"Oncol Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"L Gramantieri","year":"2007","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1872-034X.2009.00502.x","article-title":"Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated","volume":"39","author":"XH Huang","year":"2009","journal-title":"Hepatol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e15304","DOI":"10.1371\/journal.pone.0015304","article-title":"Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma","volume":"6","author":"Y Mizuguchi","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jgh.12216","article-title":"Cyclin E facilitates dysplastic hepatocytes to bypass G1\/S checkpoint in hepatocarcinogenesis","volume":"28","author":"S Pok","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"J Kota","year":"2009","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0120794","DOI":"10.1371\/journal.pone.0120794","article-title":"Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4","volume":"10","author":"TK Motawi","year":"2015","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1200\/JCO.2011.38.2697","article-title":"Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"J Zhou","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12013-013-9575-y","article-title":"Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia","volume":"67","author":"AA Abd-El-Fattah","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4254\/wjh.v6.i11.818","article-title":"Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma","volume":"6","author":"H El-Garem","year":"2014","journal-title":"World J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MCG.0b013e3181f18ac2","article-title":"Circulating microRNAs as biomarkers for hepatocellular carcinoma","volume":"45","author":"KZ Qu","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Y Murakami","year":"2006","journal-title":"Oncogene"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e109347","DOI":"10.1371\/journal.pone.0109347","article-title":"Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival","volume":"9","author":"M Liu","year":"2014","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20100297","article-title":"Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies","volume":"120","author":"J Gui","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"H Hermeking","year":"2007","journal-title":"Cancer Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mc.20484","article-title":"Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet","volume":"48","author":"VP Tryndyak","year":"2009","journal-title":"Mol Carcinog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e107986","DOI":"10.1371\/journal.pone.0107986","article-title":"A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus","volume":"9","author":"Y Tan","year":"2014","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","article-title":"Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance","volume":"52","author":"A Karakatsanis","year":"2013","journal-title":"Mol Carcinog"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/03009734.2013.856970","article-title":"Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues","volume":"119","author":"M Rong","year":"2014","journal-title":"Ups J Med Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-14-5","article-title":"microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma","volume":"14","author":"Z Zhang","year":"2015","journal-title":"Mol Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/onc.2011.209","article-title":"miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression","volume":"31","author":"V Vaira","year":"2012","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gde.2009.04.002","article-title":"AngiomiRs\u2014key regulators of angiogenesis","volume":"19","author":"S Wang","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/15384101.2014.977112","article-title":"miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression","volume":"14","author":"X Sun","year":"2015","journal-title":"Cell Cycle"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1478-3231.2011.02750.x","article-title":"MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt\/beta-catenin pathway","volume":"32","author":"J Xu","year":"2012","journal-title":"Liver Int"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"J Xu","year":"2011","journal-title":"Mol Carcinog"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e28486","DOI":"10.1371\/journal.pone.0028486","article-title":"Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection","volume":"6","author":"P Qi","year":"2011","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e113651","DOI":"10.1371\/journal.pone.0113651","article-title":"Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease","volume":"9","author":"D Povero","year":"2014","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"K Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2011.11.026","article-title":"Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma","volume":"56","author":"F Borel","year":"2012","journal-title":"J Hepatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"J Trebicka","year":"2013","journal-title":"J Hepatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1111\/j.1742-4658.2009.07213.x","article-title":"Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways","volume":"276","author":"CJ Guo","year":"2009","journal-title":"FEBS J"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","article-title":"miR-221 overexpression contributes to liver tumorigenesis","volume":"107","author":"P Pineau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2011.04.026","article-title":"Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma","volume":"56","author":"Y Tomimaru","year":"2012","journal-title":"J Hepatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e000825","DOI":"10.1136\/bmjopen-2012-000825","article-title":"Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study","volume":"2","author":"AM Liu","year":"2012","journal-title":"BMJ Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0137706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:53:52Z","timestamp":1589046832000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0137706"}},"subtitle":[],"editor":[{"given":"Anand S","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0137706","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]}}}